Longitudinal assessment of anti-Mullerian hormone after cesarean section and influence of bilateral salpingectomy on ovarian reserve

被引:5
|
作者
Ida, Tsutomu [1 ]
Fujiwara, Hiroyuki [2 ]
Taniguchi, Yoshimi [1 ]
Kohyama, Akira [1 ]
机构
[1] Tokyo Metropolitan Tama Med Ctr, Dept Obstet & Gynecol, Fuchu, Tokyo, Japan
[2] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan
关键词
Anti-Mullerian hormone; Cesarean section; Ovarian function; Salpingectomy; Tubal ligation; Permanent contraception; SERUM ANTIMULLERIAN HORMONE; TUBAL-LIGATION; INHIBIN-B; WOMEN; STERILIZATION; AGE; HYSTERECTOMY; PREGNANCY; CANCER;
D O I
10.1016/j.contraception.2021.01.016
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: This study aimed to compare longitudinal changes in ovarian reserve markers after cesarean section (CS) with and without bilateral salpingectomy (BS). Study design: We prospectively enrolled women >35 weeks' gestation scheduled for CS alone or CS + BS and obtained blood samples for anti-Mullerian hormone prior to surgery and at 3 and 6 months after surgery. At the 3-month visit, we similarly performed transvaginal ultrasound for antral follicle count. Results: We enrolled 50 women; 30 underwent CS only and 20 underwent CS + BS. Although anti-Mullerian hormone level increased over 6 months of follow-up in both groups, no clinically important differences in the geometric mean (interquartile range) (ng/mL) were observed at any timepoint (baseline [0.69 {0.36-1.21} {CS only} vs 0.49 {0.32-2.10} {CS + BS}, p = 0.64]; 3 months [1.35 {0.58-3.13} vs 1.45 {1.04-2.25}, p = 0.79]; and 6 months [1.74 {0.93-4.45} vs 2.60 {1.41-5.10}, p =0.27]). Similarly, we detected no difference in antral follicle count. Conclusion: BS at the time of CS does not have a negative impact on ovarian reserve 6 months after surgery. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:394 / 399
页数:6
相关论文
共 50 条
  • [1] Assessment of ovarian reserve in adult childhood cancer survivors using anti-Mullerian hormone
    Fong, S. Lie
    Laven, J. S. E.
    Hakvoort-Cammel, F. G. A. J.
    Schipper, I.
    Visser, J. A.
    Themmen, A. P. N.
    de Jong, F. H.
    van den Heuvel-Eibrink, M. M.
    HUMAN REPRODUCTION, 2009, 24 (04) : 982 - 990
  • [2] Ovarian reserve following cesarean section with salpingectomy vs tubal ligation: a randomized trial
    Herman, Hadas Ganer
    Gluck, Ohad
    Keidar, Ran
    Kerner, Ram
    Kovo, Michal
    Levran, David
    Bar, Jacob
    Sagiv, Ron
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 217 (04) : 472.e1 - 472.e6
  • [3] Effect of Salpingectomy for Hydrosalpinx or Tubal Pregnancy on the Ovarian Reserve as Measured by Serum anti-Mullerian Hormone Levels
    Murase, Tomohiko
    Iwase, Akira
    Mayama, Michinori
    Kishigami, Yasuyuki
    Oguchi, Hidenori
    Kikkawa, Fumitaka
    JOURNAL OF REPRODUCTIVE MEDICINE, 2019, 64 (3-4) : 90 - 94
  • [4] Assessment of ovarian reserve using serum anti-Mullerian hormone after ovarian torsion surgery
    Oskayli, Meltem Caglar
    Gulcin, Neslihan
    Ozatman, Erdem
    Gercel, Gonca
    Mutus, Murat
    Aksu, Burhan
    Durakbasa, Cigdem Ulukaya
    PEDIATRICS INTERNATIONAL, 2019, 61 (05) : 504 - 507
  • [5] Measuring anti-Mullerian hormone for the assessment of ovarian reserve: When and for whom is it indicated?
    Anderson, R. A.
    Nelson, S. M.
    Wallace, W. H. B.
    MATURITAS, 2012, 71 (01) : 28 - 33
  • [6] Assessment of ovarian reserve: Anti-Mullerian hormone versus follicle stimulating hormone
    Jamil, Zehra
    Fatima, Syeda Sadia
    Cheema, Zahra
    Baig, Safia
    Choudhary, Roha Ahmed
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2016, 21
  • [7] Anti-Mullerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function
    Moolhuijsen, Loes M. E.
    Visser, Jenny A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (11)
  • [8] Anti-mullerian hormone and ovarian reserve in systemic lupus erythematosus
    Esteves Martins, Nadia Filipa
    Seixas, Maria Ines
    Pereira, Joaquim Polido
    Costa, Maria Manuela
    Fonseca, Joo Eurico
    CLINICAL RHEUMATOLOGY, 2017, 36 (12) : 2853 - 2854
  • [9] Anti-Mullerian hormone, an ovarian reserve marker in hypogonadotropic hypogonadism
    Oncul, Mahmut
    Ozcivit, Ipek Betul
    Basibuyuk, Zafer
    Cebi, Ceren
    Sahmay, Sezai
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2022, 273 : 54 - 58
  • [10] Anti-Mullerian Hormone and Assessment of Ovarian Reserve After Ovarian Toxic Treatment: A Systematic Narrative Review
    Iwase, Akira
    Nakamura, Tomoko
    Nakahara, Tatsuo
    Goto, Maki
    Kikkawa, Fumitaka
    REPRODUCTIVE SCIENCES, 2015, 22 (05) : 519 - 526